Upregulation of CD38+ on activated CD8+ T cells has been widely used as a prognostic marker for various diseases, including HIV infection (15, 17) and chronic lymphocytic leukemia (80). The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.